Endothelial dysfunction and hyperhomocysteinemia in Parkinson's disease: Flow-mediated dilation study

Jung Han Yoon, Jin Soo Lee, Seok Woo Yong, Ji Man Hong, philhyu Lee

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Levodopa (l-dopa) therapy in Parkinson's disease (PD) increases serum homocysteine levels because of its metabolism via catechol O-methyltransferase, which may lead to endothelial dysfunction. Method: We enrolled 40 PD patients treated with l-dopa, 33 PD patients treated with l-dopa/entacapone, 22 untreated PD and 30 controls, and compared the flow-mediated dilation in these subjects. Results: The flow-mediated dilation was significantly lower in PD patients with l-dopa (6.0±1.8%) than in those with l-dopa/entacapone (7.2±1.1%, P=0.03), untreated PD patients (7.8±1.2%, P<0.05), and controls (8.5±2.9%, P<0.05). The homocysteine level was significantly higher in PD patients with l-dopa than in other groups. In a multivariate logistic regression model, the uppermost homocysteine quartile was an independent predictor of the lowest tertile of flow-mediated dilation (odds ratio, 6.33; 95% confidence interval, 1.61-26.65; P=0.012). Conclusions: Our findings indicate that endothelial dysfunction may be associated with chronic l-dopa treatment in patients with PD.

Original languageEnglish
Pages (from-to)1551-1555
Number of pages5
JournalMovement Disorders
Volume29
Issue number12
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Hyperhomocysteinemia
Levodopa
Parkinson Disease
Dilatation
Homocysteine
Logistic Models
Catechol O-Methyltransferase
Odds Ratio
Confidence Intervals
Therapeutics
Serum

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

Yoon, Jung Han ; Lee, Jin Soo ; Yong, Seok Woo ; Hong, Ji Man ; Lee, philhyu. / Endothelial dysfunction and hyperhomocysteinemia in Parkinson's disease : Flow-mediated dilation study. In: Movement Disorders. 2014 ; Vol. 29, No. 12. pp. 1551-1555.
@article{41e3557002c042cf9550ee3ee5892db3,
title = "Endothelial dysfunction and hyperhomocysteinemia in Parkinson's disease: Flow-mediated dilation study",
abstract = "Background: Levodopa (l-dopa) therapy in Parkinson's disease (PD) increases serum homocysteine levels because of its metabolism via catechol O-methyltransferase, which may lead to endothelial dysfunction. Method: We enrolled 40 PD patients treated with l-dopa, 33 PD patients treated with l-dopa/entacapone, 22 untreated PD and 30 controls, and compared the flow-mediated dilation in these subjects. Results: The flow-mediated dilation was significantly lower in PD patients with l-dopa (6.0±1.8{\%}) than in those with l-dopa/entacapone (7.2±1.1{\%}, P=0.03), untreated PD patients (7.8±1.2{\%}, P<0.05), and controls (8.5±2.9{\%}, P<0.05). The homocysteine level was significantly higher in PD patients with l-dopa than in other groups. In a multivariate logistic regression model, the uppermost homocysteine quartile was an independent predictor of the lowest tertile of flow-mediated dilation (odds ratio, 6.33; 95{\%} confidence interval, 1.61-26.65; P=0.012). Conclusions: Our findings indicate that endothelial dysfunction may be associated with chronic l-dopa treatment in patients with PD.",
author = "Yoon, {Jung Han} and Lee, {Jin Soo} and Yong, {Seok Woo} and Hong, {Ji Man} and philhyu Lee",
year = "2014",
month = "1",
day = "1",
doi = "10.1002/mds.26005",
language = "English",
volume = "29",
pages = "1551--1555",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

Endothelial dysfunction and hyperhomocysteinemia in Parkinson's disease : Flow-mediated dilation study. / Yoon, Jung Han; Lee, Jin Soo; Yong, Seok Woo; Hong, Ji Man; Lee, philhyu.

In: Movement Disorders, Vol. 29, No. 12, 01.01.2014, p. 1551-1555.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Endothelial dysfunction and hyperhomocysteinemia in Parkinson's disease

T2 - Flow-mediated dilation study

AU - Yoon, Jung Han

AU - Lee, Jin Soo

AU - Yong, Seok Woo

AU - Hong, Ji Man

AU - Lee, philhyu

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background: Levodopa (l-dopa) therapy in Parkinson's disease (PD) increases serum homocysteine levels because of its metabolism via catechol O-methyltransferase, which may lead to endothelial dysfunction. Method: We enrolled 40 PD patients treated with l-dopa, 33 PD patients treated with l-dopa/entacapone, 22 untreated PD and 30 controls, and compared the flow-mediated dilation in these subjects. Results: The flow-mediated dilation was significantly lower in PD patients with l-dopa (6.0±1.8%) than in those with l-dopa/entacapone (7.2±1.1%, P=0.03), untreated PD patients (7.8±1.2%, P<0.05), and controls (8.5±2.9%, P<0.05). The homocysteine level was significantly higher in PD patients with l-dopa than in other groups. In a multivariate logistic regression model, the uppermost homocysteine quartile was an independent predictor of the lowest tertile of flow-mediated dilation (odds ratio, 6.33; 95% confidence interval, 1.61-26.65; P=0.012). Conclusions: Our findings indicate that endothelial dysfunction may be associated with chronic l-dopa treatment in patients with PD.

AB - Background: Levodopa (l-dopa) therapy in Parkinson's disease (PD) increases serum homocysteine levels because of its metabolism via catechol O-methyltransferase, which may lead to endothelial dysfunction. Method: We enrolled 40 PD patients treated with l-dopa, 33 PD patients treated with l-dopa/entacapone, 22 untreated PD and 30 controls, and compared the flow-mediated dilation in these subjects. Results: The flow-mediated dilation was significantly lower in PD patients with l-dopa (6.0±1.8%) than in those with l-dopa/entacapone (7.2±1.1%, P=0.03), untreated PD patients (7.8±1.2%, P<0.05), and controls (8.5±2.9%, P<0.05). The homocysteine level was significantly higher in PD patients with l-dopa than in other groups. In a multivariate logistic regression model, the uppermost homocysteine quartile was an independent predictor of the lowest tertile of flow-mediated dilation (odds ratio, 6.33; 95% confidence interval, 1.61-26.65; P=0.012). Conclusions: Our findings indicate that endothelial dysfunction may be associated with chronic l-dopa treatment in patients with PD.

UR - http://www.scopus.com/inward/record.url?scp=84927520731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927520731&partnerID=8YFLogxK

U2 - 10.1002/mds.26005

DO - 10.1002/mds.26005

M3 - Article

C2 - 25154960

AN - SCOPUS:84927520731

VL - 29

SP - 1551

EP - 1555

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 12

ER -